Alessandra Merlini
Overview
Explore the profile of Alessandra Merlini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
169
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Delcuratolo M, Crespi V, Saba G, Mogavero A, Napoli V, Garbo E, et al.
Cancer Treat Rev
. 2025 Mar;
135:102918.
PMID: 40086102
Despite PACIFIC set a new milestone in the clinical management of unresectable stage III non-small cell lung cancer (NSCLC), it left some critical questions pending for clinical research: the efficacy...
2.
Nigro M, Marchetti A, Fumagalli E, De Luca I, Bertuzzi A, Grimaudo M, et al.
JAMA Netw Open
. 2025 Jan;
8(1):e2456058.
PMID: 39853981
Importance: The D842V platelet-derived growth factor receptor α (PDGFRA) mutation identifies a molecular subgroup of gastrointestinal stromal tumors (GISTs), primarily resistant to standard tyrosine kinase inhibitors and with an overall...
3.
Passiglia F, Listi A, Bironzo P, Merlini A, Benso F, Napoli F, et al.
J Thorac Oncol
. 2024 Dec;
PMID: 39694416
Introduction: The advocacy Women Against Lung Cancer in Europe (WALCE) promoted the European Program for the Routine Testing of Patients With Advanced Lung Cancer (EPROPA) and provided a free-of-charge molecular...
4.
Colombo C, Hakkesteegt S, Cesne A, Barretta F, Blay J, Grunhagen D, et al.
Clin Cancer Res
. 2024 Dec;
31(3):603-610.
PMID: 39620931
Purpose: Three prospective observational studies (Italy, the Netherlands, and France) on active surveillance (AS) in patients with extra-abdominal desmoid-type fibromatosis support AS as a first-line approach. Identifying prognostic factors for...
5.
Galvagno F, Leuci V, Massa A, Donini C, Rotolo R, Capellero S, et al.
Cancer Immunol Immunother
. 2024 Nov;
74(1):6.
PMID: 39487859
Intraperitoneal cellular immunotherapy with CAR-redirected lymphocytes is an intriguing approach to target peritoneal carcinomatosis (PC) from ovarian cancer (OC), which is currently evaluated in clinical trials. PC displays a composite...
6.
Picca F, Giannotta C, Tao J, Giordanengo L, Munir H, Botta V, et al.
Int J Mol Sci
. 2024 Oct;
25(19).
PMID: 39409152
Genomic-oriented oncology has improved tumor classification, treatment options, and patient outcomes. However, genetic heterogeneity, tumor cell plasticity, and the ability of cancer cells to hijack the tumor microenvironment (TME) represent...
7.
Stacchiotti S, Martini S, Pasquali S, Frezza A, Beretta A, Percio S, et al.
Clin Cancer Res
. 2024 Sep;
30(22):5122-5137.
PMID: 39283723
Purpose: Epithelioid hemangioendothelioma (EHE), an ultra-rare sarcoma, poses therapeutic challenges because of limited efficacy of conventional chemotherapy in advanced cases, necessitating exploration of new treatment avenues and identification of novel...
8.
Giordano G, Tucciarello C, Merlini A, Cutrupi S, Pignochino Y
Cell Commun Signal
. 2024 Sep;
22(1):433.
PMID: 39252029
Bone sarcomas are malignant tumors of mesenchymal origin. Complete surgical resection is the cornerstone of multidisciplinary treatment. However, advanced, unresectable forms remain incurable. A crucial step towards addressing this challenge...
9.
Akman M, Monteleone C, Doronzo G, Godel M, Napoli F, Merlini A, et al.
J Exp Clin Cancer Res
. 2024 Aug;
43(1):244.
PMID: 39198838
No abstract available.
10.
Akman M, Monteleone C, Doronzo G, Godel M, Napoli F, Merlini A, et al.
J Exp Clin Cancer Res
. 2024 Aug;
43(1):219.
PMID: 39107857
Background: In non-small cell lung cancer (NSCLC) the efficacy of chemo-immunotherapy is affected by the high expression of drug efflux transporters as ABCC1 and by the low expression of ABCA1,...